Growth Metrics

Fortress Biotech (FBIO) Operating Expenses (2016 - 2025)

Fortress Biotech has reported Operating Expenses over the past 13 years, most recently at $20.9 million for Q4 2025.

  • Quarterly results put Operating Expenses at $20.9 million for Q4 2025, down 46.43% from a year ago — trailing twelve months through Dec 2025 was $133.7 million (down 20.43% YoY), and the annual figure for FY2025 was $133.5 million, down 20.57%.
  • Operating Expenses for Q4 2025 was $20.9 million at Fortress Biotech, down from $24.4 million in the prior quarter.
  • Over the last five years, Operating Expenses for FBIO hit a ceiling of $80.3 million in Q4 2021 and a floor of $20.9 million in Q4 2025.
  • Median Operating Expenses over the past 5 years was $51.2 million (2024), compared with a mean of $53.1 million.
  • Biggest five-year swings in Operating Expenses: surged 118.37% in 2021 and later tumbled 46.43% in 2025.
  • Fortress Biotech's Operating Expenses stood at $80.3 million in 2021, then fell by 11.51% to $71.0 million in 2022, then tumbled by 44.31% to $39.6 million in 2023, then decreased by 1.53% to $39.0 million in 2024, then crashed by 46.43% to $20.9 million in 2025.
  • The last three reported values for Operating Expenses were $20.9 million (Q4 2025), $24.4 million (Q3 2025), and $52.9 million (Q2 2025) per Business Quant data.